Patent ID: 7608633

Claim:
A compound of formula I wherein Q represents R 1 , OR 1 , SR 1 , SOR 1 , SO 2 R 1 , NR 9 R 1 or a straight-chain C 1-31 alkyl or C 2-31 alkenyl or alkinyl group which is optionally interrupted by 1 or 2 groups, independently selected from O, S, SO, SO 2 , NR 9 and aryl which are optionally substituted with 1 or 2 substituents R 4 , and which are optionally substituted with 1-4 C 1-6 alkyl groups and/or 1 or 2 aryl groups, wherein the aryl groups is optionally substituted with 1 or 2 substituents R 4 ; Ar represents an aryl group selected from the group consisting of a phenyl, naphthyl, biphenyl, and 5-membered heterocylic ring and 6-membered heterocyclic ring, said aryl group containing 1 to 3 atoms selected from O, N, or S and optionally annellated using a benzene ring and further which is optionally substituted with 1 or 2 substituents R 4 ; X represents N or CR 5 ; Y represents N or CR 6 ; R 1 represents H or an aryl group which is optionally substituted with 1 or 2 substituents R 4 ; R 2 and R 3 a) independently stand for H, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl or R 7 —W, or b) together with the carbon atoms to which they are bound, form a 5- or 6-membered aromatic or heteroaromatic ring which is optionally substituted with 1 or 2 substituents R 4 ; R 4 represents C 1-6 alkyl, halogen, CF 3 , CN, NO 2 , OR 9 , S(O) 0 R 9 , COR 9 , COOR 9 , CONR 9 R 10 , SO 3 R 9 , SO 2 NR 9 R 10 , tetrazolyl or R 7 —W R 5 represents H or R 4 ; R 6 represents H, C 1-6 alkyl, halogen, CF 3 , CN, NO 2 , OR 9 , S(O) 0 R 9 , COR 9 , COOR 9 , CONR 9 R 10 , SO 3 R 9 , SO 2 NR 9 R 10 , tetrazolyl or R 8 —W; R 7 represents C 1-6 alkyl, C 2-6 alkenyl or C 2-6 alkynyl; R 8 represents C 2-6 alkyl, C 2-6 alkenyl or C 2-6 alkynyl; R 9 represents H, C 1-6 alkyl or aryl; R 10 represents H or C 1-6 alkyl; W represents COOH, SO 3 H or tetrazolyl; and o represents 0, 1 or 2; and the pharmaceutically compatible salts and esters thereof.